macro

Sanofi Considers Buying US Biotech Insmed, Bloomberg Says

Sanofi is reportedly weighing a takeover of US drugmaker Insmed, according to Bloomberg News, which cites sources close to the situation.

the same feed is available to bots and dashboards through the api. connect the api →

what happened

France's Sanofi is considering a purchase of US pharmaceutical company Insmed, Bloomberg News reported on Thursday. The report relies on people with knowledge of the situation.

No deal has been confirmed, and no terms of a possible transaction have been disclosed.

why it matters

Reports of possible takeovers typically draw investor attention to the target company's shares. If a deal went ahead, it could affect Sanofi's drug portfolio and balance sheet, but for now the matter appears to be at an early stage.

market impact

Insmed shares: reported takeover interest from Sanofi may support the stock

  • Insmed shares pressure up — possible takeover interest typically supports a target's share price

tags

instruments

InsmedSanofi

sources

  1. Sanofi Weighs Takeover Of US Drugmaker Insmed — Bloomberg News, 19 November 2026 at 15:12 UTC
  2. Sanofi weighs takeover of US drugmaker Insmed, Bloomberg News reports — Reuters, 19 November 2026 at 15:17 UTC
  3. Sanofi weighs takeover of US drugmaker Insmed, Bloomberg News reports — Reuters, 19 November 2026 at 15:25 UTC

prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.

alerts on your topics, the morning digest and the api — in your account.

get stories in real time ↗